Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More Alleles: Interim Results of an Open-Label Phase 3 Clinical Trial.
作者信息
Griese Matthias, Costa Stefano, Linnemann Rachel W, Mall Marcus A, McKone Edward F, Polineni Deepika, Quon Bradley S, Ringshausen Felix C, Taylor-Cousar Jennifer L, Withers Nicholas J, Moskowitz Samuel M, Daines Cori L
机构信息
Ludwig Maximilians University Munich, Germany.
German Center for Lung Research Munich, Germany.
出版信息
Am J Respir Crit Care Med. 2021 Feb 1;203(3):381-385. doi: 10.1164/rccm.202008-3176LE.
Abstract
摘要
Zotero 插件